BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17393301)

  • 1. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
    Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM variants and cancer risk in breast cancer patients from Southern Finland.
    Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
    BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
    Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cancer by ATM missense mutations in the general population.
    Dombernowsky SL; Weischer M; Allin KH; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Oncol; 2008 Jun; 26(18):3057-62. PubMed ID: 18565893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM missense variant P1054R predisposes to prostate cancer.
    Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
    Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
    Meyer A; John E; Dörk T; Sohn C; Karstens JH; Bremer M
    Radiother Oncol; 2004 Sep; 72(3):319-23. PubMed ID: 15450731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
    Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
    Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two ATM variants and breast cancer risk.
    Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
    Waddell N; Jonnalagadda J; Marsh A; Grist S; Jenkins M; Hobson K; Taylor M; Lindeman GJ; Tavtigian SV; Suthers G; Goldgar D; Oefner PJ; ; Taylor D; Grimmond S; Khanna KK; Chenevix-Trench G
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1169-81. PubMed ID: 17001622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
    Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
    J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
    Tapia T; Sanchez A; Vallejos M; Alvarez C; Moraga M; Smalley S; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2008 Jan; 107(2):281-8. PubMed ID: 17351744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
    Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
    Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
    Ding H; Mao C; Li SM; Liu Q; Lin L; Chen Q
    Breast Cancer Res Treat; 2011 Jan; 125(2):473-7. PubMed ID: 20544271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.